Evidence map›Paper›PMID 42371627›Full record

ArticleJAMA network open2026

Readmission and Late Mortality Among Children With Congenital Diaphragmatic Hernia.

Marine Jouannin, Pierre Pinson, Mathis Collier, Alexandre Lapillonne, Jean-Marc Tréluyer, Elsa Kermorvant-Duchemin

Abstract read
In one paragraph

Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Marine JouanninAssistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Neonatal Intensive Care Unit, Paris, France.
Pierre PinsonUniversité Paris Cité, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Clinical Research Unit and UMRS 1343 INSERM, Perinatal and Pediatric Pharmacology and Therapeutic Assessment, Paris, France.
Mathis CollierUniversité Paris Cité, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Clinical Research Unit and UMRS 1343 INSERM, Perinatal and Pediatric Pharmacology and Therapeutic Assessment, Paris, France.
Alexandre LapillonneUniversité Paris Cité, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Neonatal Intensive Care Unit, Paris, France.
Jean-Marc TréluyerUniversité Paris Cité, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Clinical Research Unit and UMRS 1343 INSERM, Perinatal and Pediatric Pharmacology and Therapeutic Assessment, Paris, France.
Elsa Kermorvant-DucheminUniversité Paris Cité, Assistance Publique-Hopitaux de Paris, Hôpital Necker-Enfants malades, Neonatal Intensive Care Unit, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Congenital diaphragmatic hernia (CDH) is a rare malformation with high neonatal mortality. Although advances in management have improved survival rates, long-term morbidity remains substantial, and its impact on the health care system, particularly hospital readmissions, remains poorly described. Objective: To describe the incidence, causes, and factors associated with hospital readmission and late mortality after discharge from the primary stay. Design, Setting, and Participants: This nationwide retrospective cohort study was conducted from 2012 to 2024 and used data from the French National Health Data System, capturing nationwide health insurance claims and hospital discharge records in France. Participants were children with CDH who underwent surgical repair within the first 6 months of life, and were discharged alive from the primary stay. Data were analyzed from January to October 2025. Main Outcomes and Measures: The main outcomes were readmission to an acute care facility within 3 years after discharge and death during follow-up. Factors associated with readmission were identified using multivariable analysis. Results: Of the 1028 included infants (median [IQR] birth weight, 3050 [2720-3410] g; 849 [82.6%] with full-term birth; 630 [61.3%] male infants), 753 had at least 3 years of follow-up (median [IQR] time of follow-up, 6.2 [2.6-9.1] years), constituting the overall sample size for the primary analysis. Of them, 546 children (72.5%) were readmitted at least once, and 182 (24.2%) required intensive care. At 3 years, 208 (38.0%), 112 (20.5%), and 127 (23.3%) children had experienced at least 1 readmission for respiratory causes, gastrointestinal and/or nutritional issues, and CDH-related surgical complications, respectively. Preterm birth (incidence rate ratio [IRR], 1.32; 95% CI, 1.10-1.60), associated congenital anomalies (IRR, 1.31; 95% CI, 1.13-1.53), a primary stay longer than 1 month (IRR, 1.50; 95% CI, 1.27-1.76), oxygen therapy at discharge (IRR, 2.14; 95% CI, 1.55-2.99), and enteral feeding at discharge (IRR, 2.21; 95% CI, 1.83-2.68) were independently associated with readmission. Fourteen late deaths (14 of 1028 infants [1.4%]) were recorded, attributable to CDH-related complications or associated comorbidities in half of cases. Enteral feeding at discharge was also independently associated with late mortality (hazard ratio, 5.09; 95% CI, 1.33-19.48). Conclusions and Relevance: In this cohort study of 1028 children with CDH, nearly three-quarters were readmitted within 3 years, but late mortality was low. Although enteral feeding at discharge likely reflected CDH severity, it may also represent a potentially modifiable target that warrants further investigation to improve outcomes.

Indexed as

Hernias, Diaphragmatic, CongenitalPatient ReadmissionFemaleFranceHumansIncidenceInfantInfant, NewbornMaleRetrospective StudiesRisk Factors

Identifiers

PMID42371627
PMCPMC13316603

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.